Loading...

Kineta, Inc.

KANASDAQ
Healthcare
Biotechnology
$0.57
$-0.26(-30.77%)

Kineta, Inc. (KA) Stock Competitors & Peer Comparison

See (KA) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
KA$0.57-30.77%7M-0.35-$1.64N/A
VRTX$460.83-1.88%118.3B-121.27-$3.80N/A
REGN$558.63-0.79%59.3B14.19$39.36+0.31%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$324.79-1.22%42.4B-154.67-$2.10N/A
ARGX$595.19+0.54%36.4B36.29$16.40N/A
BNTX$112.79-2.19%27.1B-30.03-$3.76N/A
RPRX$37.06+1.06%20.8B15.13$2.45+2.35%
SMMT$27.45-4.26%20.4B-80.74-$0.34N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

KA vs VRTX Comparison July 2025

KA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, KA stands at 7M. In comparison, VRTX has a market cap of 118.3B. Regarding current trading prices, KA is priced at $0.57, while VRTX trades at $460.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

KA currently has a P/E ratio of -0.35, whereas VRTX's P/E ratio is -121.27. In terms of profitability, KA's ROE is +0.72%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, KA is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for KA.Check VRTX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;